Published in PLoS One on May 18, 2011
Membrane trafficking of death receptors: implications on signalling. Int J Mol Sci (2013) 0.89
Nucleolin inhibits Fas ligand binding and suppresses Fas-mediated apoptosis in vivo via a surface nucleolin-Fas complex. Blood (2013) 0.88
Hallmarks of glycosylation in cancer. Oncotarget (2016) 0.86
Glycobiology of cell death: when glycans and lectins govern cell fate. Cell Death Differ (2013) 0.83
Structural Basis and Functional Role of Intramembrane Trimerization of the Fas/CD95 Death Receptor. Mol Cell (2016) 0.82
Changes in plasma membrane surface potential of PC12 cells as measured by Kelvin probe force microscopy. PLoS One (2012) 0.78
Improved production of recombinant human Fas ligand extracellular domain in Pichia pastoris: yield enhancement using disposable culture-bag and its application to site-specific chemical modifications. BMC Biotechnol (2014) 0.77
Glycosyltransferases and non-alcoholic fatty liver disease. World J Gastroenterol (2016) 0.76
Cancer Therapy Due to Apoptosis: Galectin-9. Int J Mol Sci (2017) 0.75
N-glycosylation of mouse TRAIL-R and human TRAIL-R1 enhances TRAIL-induced death. Cell Death Differ (2017) 0.75
Oral Supplementation of Glucosamine Fails to Alleviate Acute Kidney Injury in Renal Ischemia-Reperfusion Damage. PLoS One (2016) 0.75
SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling. Electrophoresis (1997) 57.27
Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol (1977) 41.93
GROMACS: fast, flexible, and free. J Comput Chem (2005) 27.22
Studies on the propagation in vitro of poliomyelitis viruses. IV. Viral multiplication in a stable strain of human malignant epithelial cells (strain HeLa) derived from an epidermoid carcinoma of the cervix. J Exp Med (1953) 25.88
FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death--inducing signaling complex. Cell (1996) 12.07
Two CD95 (APO-1/Fas) signaling pathways. EMBO J (1998) 10.42
Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. Nat Med (1999) 9.78
Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell (1993) 9.06
CONTINUOUS CULTURE OF HUMAN LYMPHOBLASTS FROM PERIPHERAL BLOOD OF A CHILD WITH ACUTE LEUKEMIA. Cancer (1965) 8.54
Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science (1989) 7.76
Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. EMBO J (1995) 7.60
Fas preassociation required for apoptosis signaling and dominant inhibition by pathogenic mutations. Science (2000) 6.98
CD95's deadly mission in the immune system. Nature (2000) 5.55
Crystal structure of the soluble human 55 kd TNF receptor-human TNF beta complex: implications for TNF receptor activation. Cell (1993) 5.37
Cytotoxic effector cells specific for B Cell lines transformed by Epstein-Barr virus are present in patients with infectious mononucleosis. Proc Natl Acad Sci U S A (1975) 4.21
Death-receptor O-glycosylation controls tumor-cell sensitivity to the proapoptotic ligand Apo2L/TRAIL. Nat Med (2007) 3.99
Life and death in peripheral T cells. Nat Rev Immunol (2007) 3.67
Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily. Sequence identity with the Fas antigen. J Biol Chem (1992) 3.48
The role of c-FLIP in modulation of CD95-induced apoptosis. J Biol Chem (1999) 3.32
Human cutaneous T cell lymphoma and leukemia cell lines produce and respond to T cell growth factor. J Exp Med (1981) 3.30
The CD95 receptor: apoptosis revisited. Cell (2007) 3.13
Essential requirement for caspase-8/FLICE in the initiation of the Fas-induced apoptotic cascade. Curr Biol (1998) 3.11
NMR structure and mutagenesis of the Fas (APO-1/CD95) death domain. Nature (1997) 3.04
Mathematical modeling reveals threshold mechanism in CD95-induced apoptosis. J Cell Biol (2004) 2.70
Diversity in cell surface sialic acid presentations: implications for biology and disease. Lab Invest (2007) 2.64
Sialic acids in human health and disease. Trends Mol Med (2008) 2.61
Derivation of rules for comparative protein modeling from a database of protein structure alignments. Protein Sci (1994) 2.56
Triggering cell death: the crystal structure of Apo2L/TRAIL in a complex with death receptor 5. Mol Cell (1999) 2.42
FLICE is predominantly expressed as two functionally active isoforms, caspase-8/a and caspase-8/b. J Biol Chem (1997) 2.29
Death receptor signaling. J Cell Sci (2005) 2.21
The Fas-FADD death domain complex structure unravels signalling by receptor clustering. Nature (2008) 2.11
The Fas-FADD death domain complex structure reveals the basis of DISC assembly and disease mutations. Nat Struct Mol Biol (2010) 2.08
GlyProt: in silico glycosylation of proteins. Nucleic Acids Res (2005) 1.97
c-FLIPR, a new regulator of death receptor-induced apoptosis. J Biol Chem (2005) 1.93
ANOLEA: a www server to assess protein structures. Proc Int Conf Intell Syst Mol Biol (1997) 1.61
Dynamics within the CD95 death-inducing signaling complex decide life and death of cells. Mol Syst Biol (2010) 1.57
Analysis of CD95 threshold signaling: triggering of CD95 (FAS/APO-1) at low concentrations primarily results in survival signaling. J Biol Chem (2007) 1.55
Phosphorylation of FADD/ MORT1 at serine 194 and association with a 70-kDa cell cycle-regulated protein kinase. J Immunol (2000) 1.43
Palmitoylation of CD95 facilitates formation of SDS-stable receptor aggregates that initiate apoptosis signaling. EMBO J (2006) 1.29
Crystallographic evidence for dimerization of unliganded tumor necrosis factor receptor. J Biol Chem (1995) 1.28
The active caspase-8 heterotetramer is formed at the CD95 DISC. Cell Death Differ (2003) 1.23
Cleavage of CD95 by matrix metalloproteinase-7 induces apoptosis resistance in tumour cells. Oncogene (2004) 1.14
Solution NMR investigation of the CD95/FADD homotypic death domain complex suggests lack of engagement of the CD95 C terminus. Structure (2010) 1.02
Differential sialylation of cell surface glycoconjugates in a human B lymphoma cell line regulates susceptibility for CD95 (APO-1/Fas)-mediated apoptosis and for infection by a lymphotropic virus. Glycobiology (1999) 1.00
Structure-function relationships of Toll-like receptor domains through homology modelling and molecular dynamics. Biochem Soc Trans (2007) 0.98
Vitamin E inhibits CD95 ligand expression and protects T cells from activation-induced cell death. J Clin Invest (2002) 0.93
Comprehensive modeling and functional analysis of Toll-like receptor ligand-recognition domains. Protein Sci (2010) 0.89
Requirement of N-glycosylation for the secretion of recombinant extracellular domain of human Fas in HeLa cells. Int J Biochem Cell Biol (2007) 0.85
Characterization of "T" and "non-T" cell lines established from children with acute lymphoblastic leukemia and non-Hodgkin lymphoma after leukemic transformation. Haematol Blood Transfus (1977) 0.84
Sialidases. Curr Protoc Mol Biol (2001) 0.82
Specificity of anti-human CD95 (APO-1/Fas) antibodies. Biochem Biophys Res Commun (2002) 0.82
Efficient routing of glucocerebrosidase to lysosomes requires complex oligosaccharide chain formation. Biochem Biophys Res Commun (1986) 0.81
Analysis of the CD95 (APO-1/Fas) death-inducing signaling complex by high-resolution two-dimensional gel electrophoresis. Methods Enzymol (2000) 0.79
IgM and IgG secretion in human B-cell lines regulated by B-cell-inducing factors (BIF) and phorbol ester. Immunol Lett (1983) 0.78
Death and anti-death: tumour resistance to apoptosis. Nat Rev Cancer (2002) 5.87
Life and death in peripheral T cells. Nat Rev Immunol (2007) 3.67
Death receptors in chemotherapy and cancer. Oncogene (2004) 2.64
Reduced suppressive effect of CD4+CD25high regulatory T cells on the T cell immune response against myelin oligodendrocyte glycoprotein in patients with multiple sclerosis. Eur J Immunol (2005) 2.28
Death receptor signaling. J Cell Sci (2005) 2.21
Pharmacologic cholinesterase inhibition improves survival in experimental sepsis. Crit Care Med (2008) 2.18
Caspases: pharmacological manipulation of cell death. J Clin Invest (2005) 2.10
Immune escape of tumors: apoptosis resistance and tumor counterattack. J Leukoc Biol (2002) 2.04
Neutralization of CD95 ligand promotes regeneration and functional recovery after spinal cord injury. Nat Med (2004) 1.95
c-FLIPR, a new regulator of death receptor-induced apoptosis. J Biol Chem (2005) 1.93
The c-FLIP-NH2 terminus (p22-FLIP) induces NF-kappaB activation. J Exp Med (2006) 1.91
TAp63alpha induces apoptosis by activating signaling via death receptors and mitochondria. EMBO J (2005) 1.90
TAp63 and DeltaNp63 in cancer and epidermal development. Cell Cycle (2007) 1.84
Accumulation of apoptotic cells in the epidermis of patients with cutaneous lupus erythematosus after ultraviolet irradiation. Arthritis Rheum (2006) 1.83
Cyclooxygenase-2 inhibition induces apoptosis signaling via death receptors and mitochondria in hepatocellular carcinoma. Cancer Res (2006) 1.82
The natural anticancer compounds rocaglamides inhibit the Raf-MEK-ERK pathway by targeting prohibitin 1 and 2. Chem Biol (2012) 1.82
Hepatocyte-specific deletion of the antiapoptotic protein myeloid cell leukemia-1 triggers proliferation and hepatocarcinogenesis in mice. Hepatology (2010) 1.75
Prevalence of newly generated naive regulatory T cells (Treg) is critical for Treg suppressive function and determines Treg dysfunction in multiple sclerosis. J Immunol (2007) 1.74
Toll and IMD pathways synergistically activate an innate immune response in Drosophila melanogaster. Mol Cell Biol (2007) 1.62
Toll-like receptors as molecular switches. Nat Rev Immunol (2006) 1.60
In contrast to effector T cells, CD4+CD25+FoxP3+ regulatory T cells are highly susceptible to CD95 ligand- but not to TCR-mediated cell death. J Immunol (2005) 1.58
Dynamics within the CD95 death-inducing signaling complex decide life and death of cells. Mol Syst Biol (2010) 1.57
Stoichiometry of the CD95 death-inducing signaling complex: experimental and modeling evidence for a death effector domain chain model. Mol Cell (2012) 1.57
Analysis of CD95 threshold signaling: triggering of CD95 (FAS/APO-1) at low concentrations primarily results in survival signaling. J Biol Chem (2007) 1.55
Identification of an N-terminal recognition site in TLR9 that contributes to CpG-DNA-mediated receptor activation. J Immunol (2009) 1.54
Suramin inhibits death receptor-induced apoptosis in vitro and fulminant apoptotic liver damage in mice. Nat Med (2004) 1.54
Upregulation of Bcl-2 is involved in the mediation of chemotherapy resistance in human small cell lung cancer cell lines. Int J Cancer (2002) 1.46
The traditional Chinese herbal compound rocaglamide preferentially induces apoptosis in leukemia cells by modulation of mitogen-activated protein kinase activities. Int J Cancer (2007) 1.45
Pillars article: T cell-derived B cell differentiation factor(s). Effect on the isotype switch of murine B cells. J. Exp. Med. 1982. 155: 734-748. J Immunol (2013) 1.43
p73 induces apoptosis by different mechanisms. Biochem Biophys Res Commun (2005) 1.42
Glucocorticoid cotreatment induces apoptosis resistance toward cancer therapy in carcinomas. Cancer Res (2003) 1.42
One, two, three--p53, p63, p73 and chemosensitivity. Drug Resist Updat (2007) 1.41
The role of CD95 in the regulation of peripheral T-cell apoptosis. Immunol Rev (2003) 1.41
Molecular mechanisms of treg-mediated T cell suppression. Front Immunol (2012) 1.41
Artesunate induces ROS-mediated apoptosis in doxorubicin-resistant T leukemia cells. PLoS One (2007) 1.40
Suppression of Mcl-1 via RNA interference sensitizes human hepatocellular carcinoma cells towards apoptosis induction. BMC Cancer (2006) 1.35
Concepts of activated T cell death. Crit Rev Oncol Hematol (2008) 1.33
Mitochondrial reactive oxygen species control T cell activation by regulating IL-2 and IL-4 expression: mechanism of ciprofloxacin-mediated immunosuppression. J Immunol (2010) 1.33
Regulation of IL4 gene expression by T cells and therapeutic perspectives. Nat Rev Immunol (2003) 1.32
IFN-gamma represses IL-4 expression via IRF-1 and IRF-2. Immunity (2002) 1.32
Knockout of myeloid cell leukemia-1 induces liver damage and increases apoptosis susceptibility of murine hepatocytes. Hepatology (2009) 1.31
Model-based dissection of CD95 signaling dynamics reveals both a pro- and antiapoptotic role of c-FLIPL. J Cell Biol (2010) 1.30
Mutant p53 gain of function: repression of CD95(Fas/APO-1) gene expression by tumor-associated p53 mutants. Oncogene (2003) 1.28
High-throughput mutation profiling of CTCL samples reveals KRAS and NRAS mutations sensitizing tumors toward inhibition of the RAS/RAF/MEK signaling cascade. Blood (2011) 1.28
Hepatocyte growth factor induces Mcl-1 in primary human hepatocytes and inhibits CD95-mediated apoptosis via Akt. Hepatology (2004) 1.28
CD molecules 2005: human cell differentiation molecules. Blood (2005) 1.27
Apoptosis in cancer--implications for therapy. Semin Oncol (2004) 1.27
Rocaglamide derivatives are immunosuppressive phytochemicals that target NF-AT activity in T cells. J Immunol (2005) 1.26
Upregulation of major histocompatibility complex class I on liver cells by hepatitis C virus core protein via p53 and TAP1 impairs natural killer cell cytotoxicity. J Virol (2003) 1.23
Mcl-1 is an anti-apoptotic factor for human hepatocellular carcinoma. Int J Oncol (2006) 1.20
Rapid suppression of cytokine transcription in human CD4+CD25 T cells by CD4+Foxp3+ regulatory T cells: independence of IL-2 consumption, TGF-beta, and various inhibitors of TCR signaling. J Immunol (2007) 1.20
Wogonin preferentially kills malignant lymphocytes and suppresses T-cell tumor growth by inducing PLCgamma1- and Ca2+-dependent apoptosis. Blood (2007) 1.20
How T lymphocytes switch between life and death. Eur J Immunol (2006) 1.20
Serine/threonine acetylation of TGFβ-activated kinase (TAK1) by Yersinia pestis YopJ inhibits innate immune signaling. Proc Natl Acad Sci U S A (2012) 1.20
A novel serine-rich motif in the intercellular adhesion molecule 3 is critical for its ezrin/radixin/moesin-directed subcellular targeting. J Biol Chem (2002) 1.17
T cell activation is driven by an ADP-dependent glucokinase linking enhanced glycolysis with mitochondrial reactive oxygen species generation. Cell Rep (2012) 1.16
Danger signaling protein HMGB1 induces a distinct form of cell death accompanied by formation of giant mitochondria. Cancer Res (2010) 1.16
Novel role for mitochondria: protein kinase Ctheta-dependent oxidative signaling organelles in activation-induced T-cell death. Mol Cell Biol (2007) 1.14
Sensing of Gram-positive bacteria in Drosophila: GNBP1 is needed to process and present peptidoglycan to PGRP-SA. EMBO J (2006) 1.13
Primary human hepatocytes--a valuable tool for investigation of apoptosis and hepatitis B virus infection. J Hepatol (2003) 1.11
HTLV-1 Tax protects against CD95-mediated apoptosis by induction of the cellular FLICE-inhibitory protein (c-FLIP). Blood (2006) 1.10
CD4(+)CD25 (+) regulatory T cells in human lupus erythematosus. Arch Dermatol Res (2008) 1.10
Lack of tumor necrosis factor-related apoptosis-inducing ligand but presence of its receptors in the human brain. J Neurosci (2002) 1.09
Wogonin sensitizes resistant malignant cells to TNFalpha- and TRAIL-induced apoptosis. Blood (2006) 1.09
Function and regulation of the CD95 (APO-1/Fas) ligand in the immune system. Semin Immunol (2003) 1.09
Caspase-2 is activated at the CD95 death-inducing signaling complex in the course of CD95-induced apoptosis. Blood (2006) 1.08
Study of human RIG-I polymorphisms identifies two variants with an opposite impact on the antiviral immune response. PLoS One (2009) 1.07
Clinical and mechanistic aspects of glucocorticoid-induced chemotherapy resistance in the majority of solid tumors. Cancer Biol Ther (2007) 1.07
HIV-1 trans-activator of transcription substitutes for oxidative signaling in activation-induced T cell death. J Immunol (2005) 1.06
Regulation of T cell apoptosis during the immune response. Curr Mol Med (2002) 1.06
Inhibition of constitutively activated nuclear factor-kappaB induces reactive oxygen species- and iron-dependent cell death in cutaneous T-cell lymphoma. Cancer Res (2009) 1.06
Death receptor signaling and its function in the immune system. Curr Dir Autoimmun (2006) 1.05
Chemotherapy-induced apoptosis in hepatocellular carcinoma involves the p53 family and is mediated via the extrinsic and the intrinsic pathway. Int J Cancer (2010) 1.05
Caspase-cleaved HPK1 induces CD95L-independent activation-induced cell death in T and B lymphocytes. Blood (2007) 1.05
Cdk1/cyclin B1 controls Fas-mediated apoptosis by regulating caspase-8 activity. Mol Cell Biol (2010) 1.03
A PP4 holoenzyme balances physiological and oncogenic nuclear factor-kappa B signaling in T lymphocytes. Immunity (2012) 1.03
Two human MYD88 variants, S34Y and R98C, interfere with MyD88-IRAK4-myddosome assembly. J Biol Chem (2010) 1.03
Phosphorylation of CARMA1 by HPK1 is critical for NF-kappaB activation in T cells. Proc Natl Acad Sci U S A (2009) 1.02
Calcium/calmodulin-dependent protein kinase II regulation of c-FLIP expression and phosphorylation in modulation of Fas-mediated signaling in malignant glioma cells. J Biol Chem (2002) 1.01
Cellular FLICE-like inhibitory proteins (c-FLIPs): fine-tuners of life and death decisions. Exp Cell Res (2012) 1.01
Tumor counterattack: fact or fiction? Cancer Immunol Immunother (2005) 0.99
Activation or suppression of NFkappaB by HPK1 determines sensitivity to activation-induced cell death. EMBO J (2005) 0.99
Hepatitis C virus core protein inhibits tumor suppressor protein promyelocytic leukemia function in human hepatoma cells. Cancer Res (2005) 0.99
Glucocorticoids inhibit activation-induced cell death (AICD) via direct DNA-dependent repression of the CD95 ligand gene by a glucocorticoid receptor dimer. Blood (2005) 0.99
Dominant negative (DeltaN) p63alpha induces drug resistance in hepatocellular carcinoma by interference with apoptosis signaling pathways. Biochem Biophys Res Commun (2010) 0.99
Human regulatory T cells rapidly suppress T cell receptor-induced Ca(2+), NF-κB, and NFAT signaling in conventional T cells. Sci Signal (2011) 0.98
Carrageenans inhibit the in vitro growth of Plasmodium falciparum and cytoadhesion to CD36. Parasitol Res (2005) 0.98
CD95 stimulation results in the formation of a novel death effector domain protein-containing complex. J Biol Chem (2008) 0.98